Earnings dates and session timing shown here are aggregated from third-party sources, are frequently estimated, and are subject to change or confirmation by the reporting company. Nothing on this site is financial advice.
Cardio Diagnostics Holdings Inc (CDIO) is a pioneering biotechnology firm focused on enhancing cardiovascular health through innovative diagnostic solutions. The company utilizes state-of-the-art technology to equip healthcare professionals with vital tools for precise assessment and management of cardiovascular diseases, thereby improving patient outcomes. With a commitment to personalized medicine and a robust growth strategy, CDIO stands out as an attractive investment opportunity for institutional investors seeking to capitalize on advancements in the dynamic healthcare sector.
Quotes and fundamental data are delayed and provided for informational purposes only — nothing on this page is financial advice. Figures are as reported by the company and its data providers and may be revised. Estimates reflect analyst consensus at the time of each report.
$1.86
| Quarter | EPS | Revenue | Price move | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Est | Adj | Result | GAAP | Est | Actual | Surprise | 1D Pre | On-Day | 1D Post | |
Q ended Jun 30, 2026 Reported Aug 7, 2026 | — | $-0.51 | — | $-0.51 | — | $5.4K | — | 1D Pre-5.1% | On-Day+7.8% | 1D Post-4.5% |
Q ended Mar 31, 2026 Reported May 15, 2026 | — | $-0.62 | — | — | — | $2.7K | — | 1D Pre-6.1% | On-Day-7.7% | 1D Post-10.3% |
Q ended Dec 31, 2025 Reported Mar 13, 2026 | ||||||||||
Dashed outlines show the analyst consensus estimate for periods where one was published. Hover or tap a bar for exact figures. Values as reported; not adjusted for splits after the report date.
| $-0.80 |
| — |
| — |
| — |
| $3.6K |
| — |
| 1D Pre-4.2% |
| On-Day-38.6% |
| 1D Post-13.9% |
Q ended Sep 30, 2025 Reported Nov 12, 2025 | $-0.22 | $-0.98 | Miss -345.5% | — | $0 | $2.9K | — | 1D Pre-1.3% | On-Day-1.8% | 1D Post-9.1% |